it’s a good step in the right direction however if this is basically just a cough counter there’s no reason they can’t broaden their product offerings by being a fart counter to detect bowel cancer
- Forums
- ASX - By Stock
- RAP
- Ann: AstraZeneca to use new ResApp software in clinical study
Ann: AstraZeneca to use new ResApp software in clinical study, page-48
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable